Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus

Journal of Rheumatology

Volumn 27, Issue 6, 2000, Pages 1403-1407

  Nakano, Masaaki ^a   Ohuchi, Yuko ^a   Hasegawa, Hisashi ^a   Kuroda, Takeshi ^a   Ito, Satoshi ^a   Gejyo, Fumitake ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Anti CENP B antibody; Anticentromere antibody; Crest syndrome; Systemic lupus erythematosus

Indexed keywords

CELL PROTEIN; CENTROMERE ANTIBODY; CENTROMERE PROTEIN CENP B; PREDNISOLONE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CENTROMERE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SERODIAGNOSIS; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; AUTOANTIGENS; CARCINOMA, HEPATOCELLULAR; CENTROMERE; CENTROMERE PROTEIN B; CHROMOSOMAL PROTEINS, NON-HISTONE; CREST SYNDROME; CROSS-SECTIONAL STUDIES; DNA-BINDING PROTEINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; TUMOR CELLS, CULTURED;

EID: 0034082186     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Moroi Y, Peebles C, Fritzler MJ, Steingerwald J, Tan EM. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 1980;77:1627-31.
2. Fritzler MJ, Kinsella TD, Garbutt E. The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med 1980;69:520-6.
3. Ferri C, Bernini L, Cecchetti R, et al. Cutaneous and serologic subsets of systemic sclerosis. J Rheumatol 1991;18:1826-32.
4. Caramaschi P, Biasi D, Carletto A, et al. Sjögren's syndrome with anticentromere antibodies. Rev Rhum Engl Ed 1997;64:785-8.
5. Vlachoviannopoulos PG, Drosos AA, Wiik A, Moutsopoulos HM. Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol 1993;32:297-301.
6. Powell FC, Schroeter AL, Dickson ER. Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases. Q J Med 1987;237:75-82.
7. Sarkozi J, Bookman AAM, Lee P, Keystone EC, Fritzler MJ. Significance of anticentromere antibody in idiopathic Raynaud's syndrome. Am J Med 1987;83:893-8.
8. Thompson D, Juby A, Davis P. The clinical significance of autoantibody profiles in patients with systemic lupus erythematosus. Lupus 1993;2:15-9.
9. Goldman JA. Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease. Ann Rheum Dis 1989;48:771-5.
10. Caramaschi P, Biasi D, Manzo T, Carletto A, Poli F, Bambara LM. Anticentromere antibody-clinical association. A study of 44 patients. Rheumatol Int 1995;14:253-5.
11. Martin L, Pauls JD, Ryan JP, Fritzler MJ. Identification of a subset of patients with scleroderma with severe pulmonary and vascular disease by the presence of autoantibodies to centromere and histone. Ann Rheum Dis 1993;52:780-4.
12. Muro Y, Sugimoto K, Okazaki T, Ohashi M. The heterogeneity of anticentromere antibodies in immunoblotting analysis. J Rheumatol 1990;17:1042-7.
13. Senecal JL, Rothfield NF, Oliver JM. Immunoglobulin M autoantibody to vimentin intermediate filaments. J Clin Invest 1982;69:716-21.
14. Migliaresi S, Picillo U, Tirri G, Improta RDG, Palombara FL, Giordano M. Infrequency of anticentromere antibody in patients without systemic sclerosis and without Raynaud's phenomenon. Arthritis Rheum 1987;30:358-9.
15. Wade JP, Sack B, Schur PH. Anticentromere antibodies - clinical correlates. J Rheumatol 1988;15:1759-63.
16. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
17. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
18. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
19. Mcneilage LJ, Youngchaiyud U, Whittingham S. Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma. Arthritis Rheum 1989;32:54-60.
20. Weiner ES, Earnshaw WC, Senecal JL, Bordwell B, Johnson P, Rothfield NF. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. Arthritis Rheum 1988;31:378-85.
21. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
22. Czaja AJ, Nishioka M, Morshed SA, Hachiya T. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 1994;107:200-7.
23. Churg J, Bernstein J, Glassock RJ. Lupus nephritis. In: Churg J, Bernstein J, Glassock RJ, editors. Renal disease: classification and atlas of glomerular disease. New York: Igaku-shoin Medical; 1995:151-6.
24. Tubach F, Havem G, Elias A, et al. Anticentromere antibodies in rheumatologic practice are not consistently associated with scleroderma. Rev Rhum Engl Ed 1997;64:362-7.
25. Genth E, Mierau R, Genetzky P, et al. Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum 1990;33:657-65.
26. Livingston JZ, Scott TE, Wigley FM, et al. Systemic sclerosis (scleroderma): clinical, genetic, and serologic subsets. J Rheumatol 1987;14:512-8.
27. McCarty GA, Rice JR, Bembe ML, Barada FA Jr. Anticentromere antibodies: clinical correlations and associations with favorable prognosis in patients with scleroderma variants. Arthritis Rheum 1983;26:1-7.
28. Tramposch HD, Smith CD, Senecal J, Rothfield N. A long-term longitudinal study of anticentromere antibodies. Arthritis Rheum 1984;27:121-4.